Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Nov 9, 2012 · 10-Q · 40 days after period end · 0001193125-12-461190
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $2.73M | $2.75M | $2.90M |
| Net Income | -$1.55M | -$815.00K | -$1.03M |
| EPS Diluted | -$0.03 | -$0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 9, 2012 · 40 d after period end
